ABAditya Birla SL MFDirect · IDCW

Aditya Birla Sun Life Pharma & Healthcare Fund - IDCW - Direct Plan

Pharma & Health CareEquity - Sectoral Fund - Pharma & Health CareBenchmark: BSE Health Care - TRI
NAV · 15 Sep 2026₹26.05-1.03%
AUM₹1.1k Crfrom this fund's primary plan
Expense Ratio1.02%
5Y CAGR+13.84%
Exit Load1% on or before 30D, Nil after 30D
Min SIP₹100from this fund's primary plan
Launched2019

Investment Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Mandate

Equities & Equity related instruments of companies in the Pharma, Healthcare & Allied sectors80%–100%
Liquid & Money market instruments0%–20%
Other Equities & Equity related instruments0%–20%
Units of InVITs0%–10%
Units of MF0%–20%
Fund Managers
DS
Dhaval Shah
Fund Manager
Key Information
1.02%
₹100from this fund's primary plan
₹1,000
1% on or before 30D, Nil after 30D
Nil
Inception10 Jul 2019
AMCAditya Birla SL MF
Top Holdings

Portfolio holdings not disclosed for this fund yet.

Trailing Returns
PeriodReturnsCategory avg
1 Day-1.03%
1 Week-1.99%-2.62%
1 Month-1.92%-4.01%
3 Months+7.96%+0.58%
6 Months+17.77%+9.14%
9 Months+17.98%+1.98%
1 Year+16.49%+1.64%
2 Years+6.74%+0.07%
3 Years+20.97%+13.05%
4 Years+22.25%+15.78%
5 Years+13.84%+13.90%
+21.30%+16.23%

Category avg is the average return of every scheme in this fund's SEBI class (Equity - Sectoral Fund - Pharma & Health Care) over the same period. Returns up to 1 year are absolute; returns beyond 1 year are annualised (CAGR). This is Accord's own stated convention for equity-oriented schemes.

Risk Metrics
14.05%

A measure of how much a fund's returns swing up and down over time. Higher means a bumpier ride — more volatility — even if the average return ends up the same as a steadier fund.

0.61

How sensitive a fund is to overall market moves. A beta of 1 means it roughly moves in line with the market; below 1 means smaller swings than the market; above 1 means bigger swings in both directions.

1.20

How much extra return a fund earned for every unit of risk (volatility) it took on, compared to a safe, risk-free investment. Higher means better risk-adjusted performance — not just higher returns, but smarter ones.

13.48%

The extra return a fund generated above what its benchmark index would predict, given the risk it took. Positive alpha suggests the fund manager added genuine value beyond just tracking the market.

2.78

Similar to the Sharpe Ratio, but only counts downside volatility (the bad kind) rather than penalizing a fund for volatile-but-positive swings. Higher means better returns per unit of "harmful" risk.

-9.17%

The single worst peak-to-trough fall a fund has experienced over a given period — the deepest "how much would I have lost if I'd bought at the top and sold at the bottom" scenario.

Fees
1.02%
1% on or before 30D, Nil after 30D
Nil
₹100from this fund's primary plan
₹1,000
Capital Gains Tax, general rules

This is an equity-oriented fund. Under rules effective since Budget 2024 (23 July 2024):

Short-Term Capital Gains (held ≤ 12 months): taxed at a flat 20%.

Long-Term Capital Gains (held > 12 months): taxed at 12.5% on gains above ₹1.25 lakh in a financial year, with no indexation benefit.

General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.

Frequently Asked QuestionsGeneral mutual-fund FAQs, not specific to this scheme